HLB Inc
KOSDAQ:028300
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
37 000
92 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
HLB Inc
Total Liabilities
HLB Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
HLB Inc
KOSDAQ:028300
|
Total Liabilities
â‚©305B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
27%
|
|
|
Suheung Co Ltd
KRX:008490
|
Total Liabilities
â‚©554.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
SD Biosensor Inc
KRX:137310
|
Total Liabilities
â‚©965.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
93%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Total Liabilities
â‚©130.8B
|
CAGR 3-Years
138%
|
CAGR 5-Years
111%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Total Liabilities
â‚©25.6B
|
CAGR 3-Years
46%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Total Liabilities
â‚©65B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
15%
|
|
HLB Inc
Glance View
Nestled in the bustling corridors of international commerce, HLB Inc. stands as a dynamic player in the healthcare logistics and biomedical sector. Over the years, it has carved a pivotal niche through its adept coordination of high-stakes operations that drive the backbone of medical supply chains. At the heart of its operations are innovative solutions that ensure medical products — ranging from essential pharmaceuticals to state-of-the-art medical devices — navigate smoothly from manufacturers to healthcare providers. This meticulous orchestration not only bolsters the efficiency of healthcare delivery but also makes HLB Inc. an indispensable ally in the realm of modern medicine. The company’s revenue model thrives on the intricate balance of logistical prowess and cutting-edge biomedical services. By leveraging strategic partnerships and technology-driven process improvement, HLB Inc. delivers unparalleled value in both time efficiency and cost-effectiveness. Service contracts with healthcare institutions and governmental bodies serve as significant revenue channels, as the company deftly integrates its logistics network with client demand. Simultaneously, its investments in research and development keep HLB Inc. at the forefront of healthcare innovation, providing an array of bespoke solutions that cater to the evolving landscape of healthcare needs. This dual approach not only solidifies its financial performance but also reflects a commitment to advancing the frontiers of healthcare accessibility and reliability.
See Also
What is HLB Inc's Total Liabilities?
Total Liabilities
305B
KRW
Based on the financial report for Jun 30, 2025, HLB Inc's Total Liabilities amounts to 305B KRW.
What is HLB Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
27%
Over the last year, the Total Liabilities growth was 7%. The average annual Total Liabilities growth rates for HLB Inc have been -5% over the past three years , 9% over the past five years , and 27% over the past ten years .